Venture Pill

By: Sam Gordon
  • Summary

  • Your weekly dose of startups and venture capital. Brandon Osian and Sam Gordon prescribe all you'll need to get into the wonderful world of venture. From fundraising news to startup deep dives, you can expect to stay up to date with the most innovative, exciting companies out there.
    Sam Gordon
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • E140: Cyber Scooters, Supplement Stacks, and Autonomous Ubers
    Nov 14 2024

    Our Social Media Pages, follow us and engage with the Pill-grim community!

    Instagram

    Twitter

    YouTube

    TikTok

    LinkedIn

    And now for this week’s prescription:

    On this week’s dose, we start (1:46) with a breakdown on Infinite Machine, a startup designing high-performance electric scooters tailored for urban environments, which recently raised a $9.3M seed round.. Next (10:14), we spotlight SuppCo, an app designed to personalize and track users’ supplement “stacks,” supported by a $5.5M seed round. Lastly (20:40), we wrap up with a deepdive on Waymo, Alphabet’s autonomous vehicle robotaxi service, which secured a landmark $5.6B Series C round.

    Sources:

    https://www.infinitemachine.com/

    https://www.infinitemachine.com/newsroom/infinite-machine-raises-9-3m-in-seed-round-led-by-a16z-to-fuel-non-car-revolution

    https://supp.co/

    https://supp.co/about/beta

    https://waymo.com/

    https://waymo.com/blog/2024/10/investing-to-bring-the-waymo-driver-to-more-riders/

    https://www.cnbc.com/2024/10/25/alphabets-self-driving-unit-waymo-closes-5point6-billion-funding-round.html

    Music Credit: Chapter One by Cole Bauer and Dean Keeton

    https://www.instagram.com/deankeeton/?hl=en

    Show More Show Less
    32 mins
  • E139: Customer Support AI, Clinical Documentation AI, and Helicopter Ubers
    Oct 24 2024

    Our Social Media Pages, follow us and engage with the Pill-grim community!

    Join our Entre Community

    Instagram

    Twitter

    YouTube

    TikTok

    LinkedIn

    And now for this week’s prescription:

    On this week’s dose, we start (1:58) with a breakdown on Decagon, an enterprise AI platform revolutionizing customer support, following their $65M Series B. Next (9:28), we dive into Abridge, a startup using AI to automate clinical documentation, backed by a recent $250M funding round. Finally (20:11) , we wrap up with a deep dive on Joby, a company developing electric air taxis for commercial passenger service, and their additional $500M investment from Toyota.

    Sources:

    https://decagon.ai/blog/series-b

    https://www.abridge.com/

    https://techcrunch.com/2024/06/18/how-abridge-became-one-of-the-most-talked-about-healthcare-ai-startups/?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAALhF6BSj0lyZwC64cw-YB1qSaFwsl5fQBx9Q15snKLTn2J02SNzvontN6PVuSKRJiBNRZTx61UXxAzv1BC5UVLOBujaKES08ovmk859Z28za0j9HZNYL4GwEwzB-7hXaKMgjPJG1-M8ms6wXR2XcVdi1v32hX_3OaFoJBQ5VQlv0

    https://siliconangle.com/2024/10/11/healthcare-ai-startup-abridge-reportedly-raising-250m-2-5b-valuation/

    https://www.beckershospitalreview.com/digital-health/abridge-raising-250m-report.html

    https://www.jobyaviation.com/

    https://pressroom.toyota.com/toyota-to-invest-500-million-in-joby-aviation/

    Music Credit: Chapter One by Cole Bauer and Dean Keeton

    https://www.instagram.com/deankeeton/?hl=en

    Disclosure:


    The views, statements, and opinions, expressed herein by the hosts and guests are their own, and their appearance on the podcast should not be construed as reflecting the views or implied endorsement of Independent Brokerage Solutions LLC or any of its officers, employees, or agents. The statements made herein should not be considered an investment opinion, advice, or a recommendation regarding securities of any company. This podcast is produced solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy a security.

    Show More Show Less
    29 mins
  • E138: Pod Update and Interplay Learning in the News
    Sep 26 2024

    Our Social Media Pages, follow us and engage with the Pill-grim community!


    Instagram

    Twitter

    YouTube

    TikTok

    LinkedIn


    And now for this week’s prescription:


    On this week’s dose, we mix things up a bit with a status update for Sam and Brandon. The 138 week streak of weekly doses may soon come to an end. With each of us moving to new cities, there just isn’t as much time in the week as there used to be when the pod was based out of Austin. Don’t worry! We aren’t going anywhere. You just might not see a dose every single Thursday morning.


    The second half of this week’s dose is a conversational breakdown of Interplay Learning (the company Sam works for) and their recent fundraising round led by Goldman Sachs’ Inclusive Growth Fund. With that announcement, Interplay also welcomes ITI (Industrial Training International) to the family. Tune in to hear more from Sam on the news and what’s ahead!


    Sources:


    https://www.prnewswire.com/news-releases/interplay-learning-closes-growth-investment-from-goldman-sachs-alternatives-and-acquires-industrial-training-international-302252417.html


    https://www.interplaylearning.com/


    https://www.iti.com/


    Music Credit: Chapter One by Cole Bauer and Dean Keeton


    https://www.instagram.com/deankeeton/?hl=en


    Disclosure:


    The views, statements, and opinions, expressed herein by the hosts and guests are their own, and their appearance on the podcast should not be construed as reflecting the views or implied endorsement of Independent Brokerage Solutions LLC or any of its officers, employees, or agents. The statements made herein should not be considered an investment opinion, advice, or a recommendation regarding securities of any company. This podcast is produced solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy a security.

    Show More Show Less
    22 mins

What listeners say about Venture Pill

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.